Living Donor Liver Transplant for Intrahepatic Cholangiocarcinoma: An Initial Brazilian Experience
Author Information
Author(s): Eduardo de Souza Martins Fernandes, Felipe Pedreira Tavares de Mello, Ronaldo de Oliveira Andrade, Camila Liberato Girão, Camila Cesar, Leandro Savattone Pimentel, Henrique Sergio Moraes Coelho, Samanta Teixeira Basto, Munique Siqueira, Anderson Brito, Claudia Cristina Tavares de Sousa, Tercio Genzini, Orlando Jorge Martins Torres
Primary Institution: São Lucas Hospital, Rio de Janeiro, Brazil
Hypothesis
Can living donor liver transplantation be a viable option for patients with intrahepatic cholangiocarcinoma who have a good response to neoadjuvant therapy?
Conclusion
Living donor liver transplantation may be a potential therapeutic option for well-selected patients with intrahepatic cholangiocarcinoma who do not have extrahepatic disease.
Supporting Evidence
- Both patients achieved either radiological response or tumor stability for a minimum of 6 months.
- One patient completed 23 months without recurrence after transplantation.
- The study highlights the potential of living donor liver transplantation in selected cases of intrahepatic cholangiocarcinoma.
Takeaway
This study shows that two patients with a type of liver cancer were able to have successful liver transplants after receiving special treatment to shrink their tumors.
Methodology
The study presents two cases of patients with intrahepatic cholangiocarcinoma who underwent living donor liver transplantation after neoadjuvant chemotherapy.
Limitations
The number of patients is limited and the follow-up period is relatively short.
Participant Demographics
Both patients were female, aged 54 and 66, with varying medical histories including hypertension and diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website